You're contacting media contact of this press release

Title: Dr Ayomide Announces Efforts to Make FemTech Trustworthy for Women and Investors

Nigeria, 3rd Feb 2026 - In the busy corridors of a Nigerian hospital, Dr. Ayomide Owodunni repeatedly noticed a pattern: women struggling with health issues that were often misunderstood, overlooked, or dismissed. Some were unsure about their cycles, others had symptoms that were ignored in prior consultations, and many quietly managed discomfort without guidance. Treating each patient brought meaning, but Dr. Ayomide felt her impact could be far greater if effective, evidence-backed solutions reached more women.This insight inspired a bold career pivot. Dr. Ayomide left clinical practice to focus on FemTech, a rapidly growing field where startups develop innovative solutions for women’s health. She quickly observed a critical challenge: while innovation was abundant, credibility often lagged behind. Products were promoted without consistent scientific validation, messaging sometimes overstated benefits, and investor confidence could waver as a result.Today, Dr. Ayomide serves as a FemTech Credibility Advisor, helping startups navigate the balance between innovation, evidence, and trust. “Startups move quickly, launching products, pitching investors, and communicating to users, often without fully considering regulatory and credibility risks. I help them address these early, so trust is built from the start,” she explains.From Clinic Rooms to Strategic InfluenceDr. Ayomide’s work combines frontline clinical experience with a deep understanding of regulatory requirements and investor expectations. She assists founders in anticipating credibility challenges before they escalate, ensuring products are scientifically grounded and messaging is clear. By translating complex clinical and regulatory concepts into actionable strategies, she empowers startups to build p...

This press release is issued by King Newswire